1,123 Consecutive Adults with Non-APL Acute Myeloid Leukemia: The Mayo Clinic Experience

Conclusions:The current study, the largest coming from a single institution, provides practically useful information that should assist with patient consultation on AML prognosis and treatment. The study confirms the primary prognostic importance of age, karyotype and FLT3/NPM1 mutational status, in real-life practice. Novel observations included comparable value of CRi vs CR and the particularly worse prognosis associated with post-MPN AML.DisclosuresAl-Kali: Novartis: Research Funding.

Source: Blood - November 21, 2018 Category: Hematology Authors: Begna, K. H., Ali, W., Gangat, N., Elliott, M. A., Al-Kali, A., Litzow, M. R., Hook, C. C., Wolanskyj, A., Hogan, W. J., Patnaik, M. M., Pardanani, A., Zblewski, D., Chen, D., He, R., Viswanatha, D. S., Hanson, C. A., Ketterling, R. P., Tefferi, A. Tags: 613. Acute Myeloid Leukemia: Clinical Studies: Poster II Source Type: research